Veterinary Compounding Pharmacies Market
Veterinary compounding is a procedure in which drugs are prepared instantaneously described on the label of a drug in order to make it more accessible for the treatment of animals. Various forms of manipulation of drugs in a veterinary compounding practice include the change of drug’s original dosage form, the addition of different flavours to the drug in order to make it as more palatable to animals, changing the concentration and dilution of a drug, mixing of multiple drugs into the single-dose application.
Rise in the adoption of companion animals, inclination towards customized or tailored dosage of drugs, in order to enhance compliance of animals with an alternate route of administration and flavours of the drugs are expected to boost the demand for animal compounding pharmacies. Increased focus of dispensing smooth, creamy and non-gritty drugs to the animals, rise in the availability of different flavours in the dosages of the drugs which are given by compounding pharmacists, growing awareness of generic medications in veterinary healthcare among the pet owners are the few factors which are expected to fuel the growth of veterinary compounding pharmacies market.
Veterinary Compounding Pharmacies Market Scope
Veterinary Compounding Pharmacies Market is segmented on basis of type of livestock, product type, and Geographical regions.
Based on the type of animal, the global veterinary compounding pharmacies market is segmented:
Based on the type of dosage form, the global veterinary compounding pharmacies market is segmented:
- Flavoured Liquids
- Tablet Triturates
- Flavoured pastes
Contemporarily there are many drugs which are approved to treat animals. Unmet therapeutic needs to treat rare diseases in animals are expected to create demand for compounded drugs. As exemplary, many chemotherapeutic drugs which are approved by FDA are used for the cancer treatment of cats and dogs. The safest and effective therapy which is used for the treat cats with chronic constipation is banned from US stores, few such factors are reportedly increasing the trend and adoption of the veterinary compounding pharmacies globally.
Veterinary compounding pharmacies market is segmented into North America, Asia-Pacific, Europe, and the Middle East & Africa, Latin America. Veterinary compounding pharmacies market is dominated by North America followed by Europe due to increasing practitioners in veterinary and well established veterinary healthcare. Asia Pacific market is expected to create new opportunities for the market players due to increase in the adoption of animals, growing health concerns about the pets in China and India.
Some of the players in veterinary compounding pharmacies market are Triangle Compounding Pharmacy Inc. (U.S), Diamondback Drugs LLC (U.S), Lorraine’s Pharmacy (Ontario), Medisca Inc. (Canada), Slade Dispensary Services (Australia), Wedgewood Pharmacy (U.S), Essential Pharmacy Compounding Vet (Kohll’s Pharmacy & Homecare) (U.S).
- In Jan 2016, Ceva Santé Animale and Zoion Pharma Inc. came into a collaboration for the development of epithelial sodium channel (ENaC) inhibitor for the treatment of veterinary ocular surface diseases.
Veterinary compounding pharmacies market Report Outline:
- The report provides granular level information about the market size, regional market share, and forecast from 2017-2023
- The report covers in-detail insights about the competitor’s overview, key findings, and their key strategies
- The report outlines drivers, restraints, challenges, and trends that are currently faced by the industry
- The report tracks recent innovations, key developments, and startup’s details that are working in the industry
- The report provides plethora of information about market entry strategies, regulatory framework, and reimbursement scenario